1 Monaco, G. et al. RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. Cell reports 26, 1627-1640 e1627, doi:10.1016/j.celrep.2019.01.041 (2019).
2 Wilson, J. A. et al. RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. PLoS pathogens 13, e1006155, doi:10.1371/journal.ppat.1006155 (2017).
3 Xiong, Y. et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging microbes & infections 9, 761-770, doi:10.1080/22221751.2020.1747363 (2020).
4 Singh, D. K. et al. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nat Microbiol 6, 73-86, doi:10.1038/s41564-020-00841-4 (2021).
5 Rosa, B. A. et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol 4, 290, doi:10.1038/s42003-021-01829-4 (2021).
6 Ziegler, C. G. K. et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell 181, 1016-1035 e1019, doi:10.1016/j.cell.2020.04.035 (2020).
7 Speranza, E. et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med 13, doi:10.1126/scitranslmed.abe8146 (2021).
8 Lee, J. S. et al. Single-cell Transcriptome of Bronchoalveolar Lavage Fluid Reveals Dynamic Change of Macrophages During SARS-CoV-2 Infection in Ferrets. bioRxiv, 2020.2011.2018.388280, doi:10.1101/2020.11.18.388280 (2020).
9 Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 26, 842-844, doi:10.1038/s41591-020-0901-9 (2020).
10 Saichi, M. et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol 23, 538-551, doi:10.1038/s41556-021-00681-2 (2021).
11 Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature, doi:10.1038/s41586-021-03569-1 (2021).
12 Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med 27, 904-916, doi:10.1038/s41591-021-01329-2 (2021).
13 Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895-1913 e1819, doi:10.1016/j.cell.2021.01.053 (2021).
14 Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature medicine, doi:10.1038/s41591-020-0944-y (2020).
15 Xiang, Q. et al. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs. Frontiers in Immunology 12, doi:10.3389/fimmu.2021.661052 (2021).
16 Aryanpur, M. et al. Reduced Phagocytic Capacity of Blood Monocyte/Macrophages in Tuberculosis Patients Is Further Reduced by Smoking. Iran J Allergy Asthma Immunol 15, 174-182 (2016).
17 Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29, 165-178 e168, doi:10.1016/j.chom.2020.11.013 (2021).
18 Ganatra, S. R. et al. Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J Clin Invest 130, 5171-5179, doi:10.1172/JCI136502 (2020).
19 Cai, Y. et al. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans. J Immunol 192, 2821-2829, doi:10.4049/jimmunol.1302269 (2014).
20 Garber, E. A., Hreniuk, D. L., Scheidel, L. M. & van der Ploeg, L. H. Mutations in murine Mx1: effects on localization and antiviral activity. Virology 194, 715-723, doi:10.1006/viro.1993.1312 (1993).
21 Zurcher, T., Pavlovic, J. & Staeheli, P. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol 66, 5059-5066, doi:10.1128/JVI.66.8.5059-5066.1992 (1992).
22 Nakayama, M., Nagata, K. & Ishihama, A. Enzymatic properties of the mouse Mx1 protein-associated GTPase. Virus Res 22, 227-234, doi:10.1016/0168-1702(92)90054-d (1992).
23 Nakayama, M., Nagata, K., Kato, A. & Ishihama, A. Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is GTPase. J Biol Chem 266, 21404-21408 (1991).
24 Jin, H. K., Takada, A., Kon, Y., Haller, O. & Watanabe, T. Identification of the murine Mx2 gene: interferon-induced expression of the Mx2 protein from the feral mouse gene confers resistance to vesicular stomatitis virus. J Virol 73, 4925-4930, doi:10.1128/JVI.73.6.4925-4930.1999 (1999).
25 Zurcher, T., Pavlovic, J. & Staeheli, P. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 187, 796-800, doi:10.1016/0042-6822(92)90481-4 (1992).
26 Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M. & Stark, G. R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38, 745-755, doi:10.1016/0092-8674(84)90270-8 (1984).
27 Sajid, M. et al. The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression. Front Immunol 12, 634937, doi:10.3389/fimmu.2021.634937 (2021).
28 Qi, Y. et al. IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells. PLoS One 10, e0132743, doi:10.1371/journal.pone.0132743 (2015).
29 Park, G. H. et al. Association between Interferon-Inducible Protein 6 (IFI6) Polymorphisms and Hepatitis B Virus Clearance. Genomics Inform 11, 15-23, doi:10.5808/GI.2013.11.1.15 (2013).
30 Jiang, Z. et al. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection. Nat Microbiol, doi:10.1038/s41564-021-00907-x (2021).
31 Monroe, K. M. et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343, 428-432, doi:10.1126/science.1243640 (2014).
32 Gariano, G. R. et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog 8, e1002498, doi:10.1371/journal.ppat.1002498 (2012).
33 Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11, 997-1004, doi:10.1038/ni.1932 (2010).
34 Power, D. et al. IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency. Virology 481, 142-150, doi:10.1016/j.virol.2015.02.046 (2015).
35 Kitamura, A., Takahashi, K., Okajima, A. & Kitamura, N. Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem 224, 877-883, doi:10.1111/j.1432-1033.1994.00877.x (1994).
36 Mears, H. V. & Sweeney, T. R. Better together: the role of IFIT protein-protein interactions in the antiviral response. J Gen Virol 99, 1463-1477, doi:10.1099/jgv.0.001149 (2018).
37 Zhou, X. et al. Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci 9, 200-208, doi:10.7150/ijbs.5613 (2013).
38 Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13, 46-57, doi:10.1038/nri3344 (2013).
39 Freitas, B. T., Scholte, F. E. M., Bergeron, E. & Pegan, S. D. How ISG15 combats viral infection. Virus Res 286, 198036, doi:10.1016/j.virusres.2020.198036 (2020).
40 Ritchie, K. J. et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 10, 1374-1378, doi:10.1038/nm1133 (2004).
41 D'Cunha, J. et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157, 4100-4108 (1996).
42 D'Cunha, J., Knight, E., Jr., Haas, A. L., Truitt, R. L. & Borden, E. C. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 93, 211-215, doi:10.1073/pnas.93.1.211 (1996).
43 Fagone, P. et al. Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. Antiviral Res 131, 66-73, doi:10.1016/j.antiviral.2016.04.009 (2016).
44 Chai, Y. et al. IL-29 and IFN-alpha regulate the expression of MxA, 2',5'-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells. Mol Biol Rep 38, 139-143, doi:10.1007/s11033-010-0087-1 (2011).
45 Woods, M. W. et al. Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export. Retrovirology 11, 27, doi:10.1186/1742-4690-11-27 (2014).
46 Wong, J. J., Pung, Y. F., Sze, N. S. & Chin, K. C. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 103, 10735-10740, doi:10.1073/pnas.0600397103 (2006).
47 Dastur, A., Beaudenon, S., Kelley, M., Krug, R. M. & Huibregtse, J. M. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281, 4334-4338, doi:10.1074/jbc.M512830200 (2006).
48 Doehn, J. M. et al. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection, doi:10.1007/s15010-021-01606-9 (2021).
49 Akiyama, H. et al. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon. J Virol 91, doi:10.1128/JVI.00972-17 (2017).
50 Martinez-Pomares, L. & Gordon, S. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 33, 66-70, doi:10.1016/j.it.2011.11.001 (2012).
51 Ludewig, B. & Cervantes-Barragan, L. CD169(+) macrophages take the bullet. Nat Immunol 13, 13-14, doi:10.1038/ni.2189 (2011).
52 Park, M. D. Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol 20, 351, doi:10.1038/s41577-020-0317-2 (2020).
53 Boumaza, A. et al. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis. J Infect Dis, doi:10.1093/infdis/jiab044 (2021).
54 Brito, B. P. et al. Association between caudal fold tuberculin test responses and results of an ELISA for Mycobacterium avium subsp paratuberculosis and mycobacterial culture of feces in tuberculosis-free dairy herds. J Am Vet Med Assoc 244, 582-587, doi:10.2460/javma.244.5.582 (2014).
55 Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94-101, doi:10.1038/s41586-020-1943-3 (2020).
56 Dukhanina, E. A. et al. A new role for PGRP-S (Tag7) in immune defense: lymphocyte migration is induced by a chemoattractant complex of Tag7 with Mts1. Cell Cycle 14, 3635-3643, doi:10.1080/15384101.2015.1104440 (2015).
57 Sharapova, T. N., Romanova, E. A., Sashchenko, L. P. & Yashin, D. V. Tag7-Mts1 Complex Induces Lymphocytes Migration via CCR5 and CXCR3 Receptors. Acta Naturae 10, 115-120 (2018).
58 Lancioni, C. L. et al. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. Infect Immun 79, 663-673, doi:10.1128/IAI.00806-10 (2011).
59 Gopal, R. et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am J Respir Crit Care Med 188, 1137-1146, doi:10.1164/rccm.201304-0803OC (2013).
60 Scott, N. R. et al. S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J Clin Invest 130, 3098-3112, doi:10.1172/JCI130546 (2020).
61 Donato, R., Sorci, G. & Giambanco, I. S100A6 protein: functional roles. Cell Mol Life Sci 74, 2749-2760, doi:10.1007/s00018-017-2526-9 (2017).
62 Hernandez, J. L. et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS One 8, e72480, doi:10.1371/journal.pone.0072480 (2013).
63 Wen, X. et al. Quantitative shear wave elastography in primary invasive breast cancers, based on collagen-S100A4 pathology, indicates axillary lymph node metastasis. Quant Imaging Med Surg 10, 624-633, doi:10.21037/qims.2020.02.18 (2020).
64 Pacella, I. et al. ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion. Clin Transl Immunology 9, e1221, doi:10.1002/cti2.1221 (2020).
65 Cameron, M. J. et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81, 8692-8706, doi:10.1128/JVI.00527-07 (2007).
66 Zuo, W., Zhao, X. & Chen, Y. G. SARS Coronavirus and Lung Fibrosis. Molecular Biology of the SARS-Coronavirus, 247-258, doi:10.1007/978-3-642-03683-5_15 (2009).
67 Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, doi:10.1126/science.abd4570 (2020).
68 Wang, Z., Pan, H. & Jiang, B. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients. Signal Transduct Target Ther 5, 198, doi:10.1038/s41392-020-00306-4 (2020).
69 Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S. & Huang, C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Res 179, 104811, doi:10.1016/j.antiviral.2020.104811 (2020).
70 Lokugamage, K. G. et al. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. J Virol 94, doi:10.1128/JVI.01410-20 (2020).
71 Lin, F. & Shen, K. Type I interferon: From innate response to treatment for COVID-19. Pediatr Investig 4, 275-280, doi:10.1002/ped4.12226 (2020).
72 Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718-724, doi:10.1126/science.abc6027 (2020).
73 Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, doi:10.1126/science.abd4585 (2020).
74 Park, A. & Iwasaki, A. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell host & microbe 27, 870-878, doi:10.1016/j.chom.2020.05.008 (2020).
75 Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601-605, doi:10.1038/nature13554 (2014).
76 Ganatra, S. R. et al. Anti-retroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV co-infection model. J Clin Invest, doi:10.1172/JCI136502 (2020).
77 Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe, doi:10.1016/j.chom.2020.11.013 (2020).
78 Miyahara, E. et al. Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms. FEMS Microbiol Lett 317, 109-116, doi:10.1111/j.1574-6968.2011.02215.x (2011).
79 Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888-1902 e1821, doi:10.1016/j.cell.2019.05.031 (2019).
80 Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95-102, doi:10.1038/s41586-019-1817-8 (2020).
81 Cabello-Aguilar, S. et al. SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics. Nucleic Acids Res 48, e55, doi:10.1093/nar/gkaa183 (2020).